By Kristi Willett LEXINGTON, Ky. (July 24, 2019) – The Pulmonary Fibrosis Foundation (PFF) has announced the expansion of its nationwide Care Center Network with the selection of eight additional sites, including UK HealthCare's Pulmonary, Critical Care and Sleep Medicine Clinic. More than 200,000 Americans are living with pulmonary fibrosis, a devastating disease which causes progressive scarring in the lungs. Fifty-thousand new cases of PF are diagnosed each year. Idiopathic pulmonary fibrosis, the most common form of the disease, has no known cause and no known cure.

Kristi Grider still tears up when she talks about the day she took her two-month-old son, Kenton, now seven years old, for follow-up hearing testing. His newborn hearing screen, which almost all children receive in U.S. hospitals before they go home, had indicated a potential abnormality, but she was told that her baby probably just had fluid in his ears and that she needn’t worry. 

An estimated 21 million Americans struggle with substance use disorders each year. Unfortunately, according to the Substance Abuse and Mental Health Services Administration, only about 10 percent of those people are able to access treatment. Few regions have been hit harder by the drug epidemic than Kentucky and need increased access to evidence-based treatment for substance use disorders. The University of Kentucky Department of Psychiatry saw that need and developed a new clinic to better support patients.

In an editorial published in CNS Spectrums, Dr. Jay Avasarala takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).

By Kristi Willett June 24, 2019 LEXINGTON, Ky. (June 24, 2019) — The Markey Cancer Center at Lexington Clinic began providing services on Monday to patients as part of an agreement between UK HealthCare and Lexington Clinic that enhances and expands outpatient cancer care throughout Central Kentucky. Medical oncology and infusion services at 1221 South Broadway in Lexington, and oncology, infusion and radiation therapy services at 793 Eastern Bypass, Suite G2 in Richmond, are now being provided collaboratively between the two organizations.

View the epub on physiology.org by clicking here.

LEXINGTON, Ky. (July 3, 2019)  Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It’s financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion by about the time children born today are having children of their own.

LEXINGTON, Ky. (April 19, 2019) — What impact does University of Kentucky research have on the Commonwealth? The UK Research 2018 Annual Report provides a snapshot of UK’s research: from the opening of the Healthy Kentucky Research Building, to statewide economic impact and national R&D rankings, to innovative federally funded research projects in the six areas that fall under a new program — the Research Priorities Initiative.